Teladoc Q2 FY26 net loss widens 19% to USD 38.9 million; revenue drops 4% to USD 606.9 million

• Teladoc Health posted Q2 2026 revenue of USD 606.9 million, down 4% from a year earlier.
• Net loss widened to USD 38.9 million, or USD 0.21 per share.
• Non-GAAP adjusted EBITDA slipped 5% to USD 65.7 million, as BetterHelp’s adjusted EBITDA fell to USD 471,000 from USD 11.86 million.
• Integrated Care revenue rose 1% to USD 394.3 million, while BetterHelp revenue dropped 12% to USD 212.6 million on accelerating cash-pay pressure.
• Teladoc launched Teladoc One in the U.S. and cut its full-year revenue outlook to USD 2.36 billion–USD 2.45 billion; it sees non-GAAP adjusted EBITDA of USD 271 million–USD 303 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Teladoc Health Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202607291605PRIMZONEFULLFEED9800358) on July 29, 2026, and is solely responsible for the information contained therein.